Adicet Bio, Inc.
NASDAQ:ACETBiotechnology
Healthcare
$5.53 +0.25%
+$0.02 today
- Market cap
- $51.70M
- Beta
- 1.57
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$10.13
52W Low $6.01High $17.44
Volume 0.15M
Average 0.12M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$122.11M
FY 2025 · Annual
Net Income
-$116.80M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 9.73M | 24.99M | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 6.38M |
| Gross Profit | 9.73M | 24.99M | 0 | 0 | (6.38M) |
| Gross Margin | 100.0% | 100.0% | — | — | — |
| Research & Development | 48.94M | 71.25M | 106.04M | 99.32M | 99.13M |
| Selling, General & Admin | 22.22M | 26.3M | 26.53M | 28.29M | 22.99M |
| Operating Expenses | 71.16M | 97.54M | 152.04M | 127.62M | 115.73M |
| Depreciation & Amortization | 1.54M | 5.01M | 6.1M | 6.47M | 6.38M |
| EBITDA | (60.41M) | (64.7M) | (136.54M) | (110.65M) | (110.39M) |
| EBITDA Margin | -620.9% | -258.9% | — | — | — |
| Operating Income | (61.43M) | (72.55M) | (152.04M) | (127.62M) | (122.11M) |
| Operating Margin | -631.4% | -290.3% | — | — | — |
| Interest Income | 91K | 3.76M | 9.98M | 10.71M | 5.78M |
| Interest Expense | 176K | 80K | 25K | 4K | 36K |
| Other Income / Expenses | (691K) | 2.76M | 9.38M | 10.49M | 5.31M |
| Income Before Tax | (62.12M) | (69.79M) | (142.66M) | (117.12M) | (116.8M) |
| Pre-Tax Margin | -638.5% | -279.3% | — | — | — |
| Income Tax Expense | (125K) | 0 | 0 | 0 | 0 |
| Net Income | (62M) | (69.79M) | (142.66M) | (117.12M) | (116.8M) |
| Net Margin | -637.2% | -279.3% | — | — | — |
| EPS (Basic) | (32.00) | (27.20) | (52.96) | (21.28) | (16.95) |
| EPS (Diluted) | (32.00) | (27.20) | (52.96) | (21.28) | (16.95) |
| 1.93M | 2.57M | 2.69M | 5.49M | 6.89M | |
| 1.93M | 2.57M | 2.69M | 5.49M | 6.89M |
ACET Earnings Waterfall · TTM
NASDAQ:ACET · Revenue to Net Income
Key Ratios
EPS$-14.90
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.6
P/S Ratio0.0
Analysis
$0 of revenue converted into -$108.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-14.90, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Sep 8, 2026 | |
| 8-K | Current report | Sep 1, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 7, 2026 | |
| 10-Q | Quarterly report | Aug 5, 2026 |
How much revenue does ACET generate?
Adicet Bio, Inc. (ACET) reported $0.00 of revenue in fiscal 2025.
Is ACET profitable?
Adicet Bio, Inc. (ACET) reported -$116.80M of net income.
Continue the stock analysis
Jump to another research area for this company.